ZA200300712B - Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome. - Google Patents

Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.

Info

Publication number
ZA200300712B
ZA200300712B ZA200300712A ZA200300712A ZA200300712B ZA 200300712 B ZA200300712 B ZA 200300712B ZA 200300712 A ZA200300712 A ZA 200300712A ZA 200300712 A ZA200300712 A ZA 200300712A ZA 200300712 B ZA200300712 B ZA 200300712B
Authority
ZA
South Africa
Prior art keywords
mucositis
behcet
stomatitis
syndrome
treatment
Prior art date
Application number
ZA200300712A
Other languages
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of ZA200300712B publication Critical patent/ZA200300712B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA200300712A 2000-07-28 2003-01-27 Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome. ZA200300712B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001732A IT1318649B1 (it) 2000-07-28 2000-07-28 Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.

Publications (1)

Publication Number Publication Date
ZA200300712B true ZA200300712B (en) 2004-02-09

Family

ID=11445589

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200300712A ZA200300712B (en) 2000-07-28 2003-01-27 Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.

Country Status (26)

Country Link
US (1) US20020173485A1 (xx)
EP (1) EP1313489B1 (xx)
JP (1) JP2004505028A (xx)
KR (1) KR100761051B1 (xx)
CN (1) CN1198625C (xx)
AR (1) AR030068A1 (xx)
AT (1) ATE289512T1 (xx)
AU (2) AU2002212113B2 (xx)
BR (1) BRPI0112962B8 (xx)
CA (1) CA2424346C (xx)
CZ (1) CZ301461B6 (xx)
DE (1) DE60109044T2 (xx)
ES (1) ES2236324T3 (xx)
HK (1) HK1059215A1 (xx)
HR (1) HRP20030046B1 (xx)
IT (1) IT1318649B1 (xx)
MX (1) MXPA03000712A (xx)
MY (1) MY130477A (xx)
NO (1) NO329574B1 (xx)
NZ (1) NZ523832A (xx)
PL (1) PL204397B1 (xx)
PT (1) PT1313489E (xx)
RU (1) RU2272636C2 (xx)
UA (1) UA79075C2 (xx)
WO (1) WO2002009637A2 (xx)
ZA (1) ZA200300712B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
NZ549469A (en) 2001-02-15 2009-02-28 Access Pharma Inc Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
RU2308954C2 (ru) 2002-05-09 2007-10-27 Медиджинез Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови
US20060234977A1 (en) * 2003-01-23 2006-10-19 Gina Wenham Antiviral compostion comprising a sulphated glucose polymer and a bacteriostatic agent
GB0312485D0 (en) * 2003-05-30 2003-07-09 Dodson & Horrell Horse food composition
ITMI20031291A1 (it) 2003-06-25 2004-12-26 Ricerfarma Srl Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
AU2003265624B2 (en) * 2003-08-21 2011-03-31 Abeona Therapeutics Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP2489338B1 (en) * 2006-08-28 2014-05-14 Rexaderm, INC. Dry wound dressing and drug delivery system
KR100758636B1 (ko) * 2006-12-19 2007-09-13 고려대학교 산학협력단 생체 점막 점착성 고분자 접합체 및 이의 제조방법
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
SI3354276T1 (sl) 2007-11-13 2020-09-30 Meritage Pharma, Inc. Sestavki za zdravljenje gastrointestinalnega vnetja
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
GB0813589D0 (en) * 2008-07-24 2008-09-03 Sinclair Pharmaceuticals Ltd Composition
PT2435021E (pt) * 2009-05-25 2013-09-30 Sofar Swiss Sa Utilização de uma combinação fixa de glicosaminoglicano e composição mastigável compreendendo a referida combinação fixa
JP6306349B2 (ja) 2010-04-14 2018-04-04 アルトリア クライアント サービシーズ リミテッド ライアビリティ カンパニー 予成形無煙タバコ製品
CA2815639C (en) * 2010-11-12 2016-11-08 Colgate-Palmolive Company Dual phase mouthwase
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
ITMI20110954A1 (it) * 2011-05-26 2012-11-27 Professional Dietetics Srl Combinazioni per il trattamento delle mucositi vaginali o rettali
US10799548B2 (en) * 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
CA2964064C (en) 2013-10-16 2022-07-05 Orahealth Corporation Treating mucosal lesions with hyaluronan delivered from an adhering troche
CN105342987A (zh) * 2015-12-04 2016-02-24 亚飞（上海）生物医药科技有限公司 一种凝胶及其制备方法和应用
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
US10842741B2 (en) * 2016-07-27 2020-11-24 Ritapharma, Co., Ltd. Oral mucosa application material and method for producing same therefor
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
CN106176863A (zh) * 2016-08-04 2016-12-07 陈广圣 一种医用抗菌剂
CN107802641A (zh) * 2016-09-09 2018-03-16 李明典 口腔软组织(牙龈、粘膜)抗发炎酸痛剂
EP3459368A1 (en) * 2017-09-20 2019-03-27 Geophyt S.r.L. Food integrator for antineoplastic therapies
CN109331023A (zh) * 2018-11-12 2019-02-15 沈阳药科大学 甘草次酸的医药用途
KR102475125B1 (ko) 2019-08-07 2022-12-07 고려대학교 산학협력단 일산화질소 복합체를 포함하는 구강 점막염 치료용 조성물 및 구강 점막염 치료제
AU2020372237A1 (en) * 2019-10-25 2022-05-19 Mucocort Ab Treatment of inflammatory condition in mucous membrane or skin
IT202100011879A1 (it) * 2021-05-10 2022-11-10 Aurora Biofarma S R L Composizione orale per il trattamento delle esofagiti

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092442B (en) * 1981-02-06 1984-02-08 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity containing glycyrrhetinic acid or a derivative thereof
ZA82361B (en) * 1981-02-06 1982-12-29 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity
JPS6117510A (ja) * 1984-07-03 1986-01-25 Toyobo Co Ltd 口腔粘膜適用徐放性ニフエジピン製剤
JPS6440423A (en) * 1987-08-05 1989-02-10 Kyukyu Yakuhin Kogyo Kk Patch for mucosa in oral cavity
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
JPH09169652A (ja) * 1995-12-18 1997-06-30 Lion Corp 水性液状組成物
JPH10182390A (ja) * 1996-12-25 1998-07-07 Lion Corp 口腔用組成物
JP2000178185A (ja) * 1998-12-18 2000-06-27 Lion Corp 口腔粘膜付着型徐放性錠剤

Also Published As

Publication number Publication date
BRPI0112962B8 (pt) 2021-05-25
MY130477A (en) 2007-06-29
NO20030411L (no) 2003-01-27
ATE289512T1 (de) 2005-03-15
CN1198625C (zh) 2005-04-27
NO20030411D0 (no) 2003-01-27
WO2002009637A3 (en) 2002-12-05
WO2002009637A2 (en) 2002-02-07
ITMI20001732A1 (it) 2002-01-28
CZ301461B6 (cs) 2010-03-10
EP1313489A2 (en) 2003-05-28
UA79075C2 (uk) 2007-05-25
CN1474700A (zh) 2004-02-11
AU1211302A (en) 2002-02-13
RU2272636C2 (ru) 2006-03-27
EP1313489B1 (en) 2005-02-23
MXPA03000712A (es) 2004-11-01
PT1313489E (pt) 2005-05-31
KR100761051B1 (ko) 2007-10-04
BR0112962B1 (pt) 2013-12-31
US20020173485A1 (en) 2002-11-21
ITMI20001732A0 (it) 2000-07-28
HK1059215A1 (en) 2004-06-25
NZ523832A (en) 2003-09-26
PL362921A1 (en) 2004-11-02
CA2424346C (en) 2010-03-09
KR20030069979A (ko) 2003-08-27
BR0112962A (pt) 2003-06-24
NO329574B1 (no) 2010-11-15
JP2004505028A (ja) 2004-02-19
DE60109044D1 (de) 2005-03-31
AU2002212113B2 (en) 2006-01-12
HRP20030046A2 (en) 2004-04-30
HRP20030046B1 (en) 2011-08-31
AR030068A1 (es) 2003-08-13
PL204397B1 (pl) 2010-01-29
CA2424346A1 (en) 2002-02-07
IT1318649B1 (it) 2003-08-27
DE60109044T2 (de) 2005-07-21
ES2236324T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
ZA979220B (en) New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions.
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
HUP0402113A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
MXPA01012184A (es) Composicion dietetica o farmaceutica para utilizarse en la prevencion o tratamiento de la hiperoxaluria.
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
EP1257255A4 (en) THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
HUP0301506A3 (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
HUP0203275A3 (en) 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
SI1313489T1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
MD980129A (en) Antiherpetic remedy
HK1052176A1 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments.
ITTO950545A0 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro prepara-zione ed impiego.
ZA981275B (en) Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions.
HK1045506A1 (en) Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods
ZA200104744B (en) Compositions comprising 1,1,1,3, 3-pentafluorobutane and use of said compositions.